Nuvation Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	26.75	7.87	-	-	-	-
Cost of Revenue	12.24	7.08	-	-	-	-
Gross Profit	14.51	0.8	-	-	-	-
Selling, General & Admin	137.37	69.23	28.53	31.92	24.28	10.95
Research & Development	110.11	99.12	71.29	87.82	65.25	32.6
Operating Expenses	247.48	168.35	99.82	119.73	89.53	43.55
Operating Income	-232.97	-167.56	-99.82	-119.73	-89.53	-43.55
Interest Expense	-7.1	-0.34	-	-	-	-
Interest & Investment Income	22.2	27.06	24.61	7.45	2.96	1.95
Other Non Operating Income (Expenses)	0.41	-2.02	-0.45	9.32	3.59	-0.27
EBT Excluding Unusual Items	-217.46	-142.86	-75.66	-102.97	-82.98	-41.88
Gain (Loss) on Sale of Investments	0.01	-0.01	-0.14	-1.23	-0.08	0.22
Pretax Income	-217.48	-567.94	-75.8	-104.2	-86.85	-41.66
Net Income	-217.48	-567.94	-75.8	-104.2	-86.85	-41.66
Net Income to Common	-217.48	-567.94	-75.8	-104.2	-86.85	-41.66
Shares Outstanding (Basic)	340	269	219	217	198	98
Shares Outstanding (Diluted)	340	269	219	217	198	98
Shares Change (YoY)	42.08%	22.79%	1.00%	9.52%	102.90%	-52.81%
EPS (Basic)	-0.64	-2.11	-0.35	-0.48	-0.44	-0.43
EPS (Diluted)	-0.64	-2.11	-0.35	-0.48	-0.44	-0.43
Free Cash Flow	-190.25	-130.58	-68.07	-96.48	-68.47	-36.67
Free Cash Flow Per Share	-0.56	-0.49	-0.31	-0.45	-0.35	-0.38
Gross Margin	54.26%	10.10%	-	-	-	-
Operating Margin	-870.98%	-2128.25%	-	-	-	-
Profit Margin	-813.07%	-7213.76%	-	-	-	-
Free Cash Flow Margin	-711.26%	-1658.52%	-	-	-	-
EBITDA	-231.55	-166.87	-99.6	-119.54	-89.35	-43.45
D&A For EBITDA	1.42	0.68	0.22	0.2	0.18	0.1
EBIT	-232.97	-167.56	-99.82	-119.73	-89.53	-43.55

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q